Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell TherapyIbrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.
Haematologica|June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patientsIbrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.
Cancer Medicine|April 21, 2023
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experienceIdoroenyi Amanam, Janny Yao, Alfredo Puing, et al.
Blood Neoplasia|September 8, 2025
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemiaAhmed Aribi, Gabriel N Mannis, Yazan F Madanat, et al.
Cancers|December 17, 2024
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)Hoda Pourhassan, Tina Nguyen, Dongyun Yang, et al.
Transplantation and Cellular Therapy|April 10, 2022
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in RemissionAnthony S Stein, Monzr M Al Malki, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALLIbrahim Aldoss, Samer K Khaled, Xiuli Wang, et al.
Transplantation and Cellular Therapy|September 21, 2025
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid LeukemiaAmandeep Salhotra, Nelli Bejanyan, Dongyun Yang, et al.
Leukemia & Lymphoma|August 3, 2023
<i>WT1</i>-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimensAhmed Aribi, Amandeep Salhotra, Michelle Afkhami, et al.
Bone Marrow Transplantation|August 15, 2024
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settingsSalman Otoukesh, Dongyun Yang, Sally Mokhtari, et al.
Pageof 7